| Page 907 | Kisaco Research
 

Sally Mueller

CO-Founder &CEO
Womaness

As the co-founder and CEO of Womaness, Sally is a consummate business builder specializing in retail and brand innovation. Her trend-forecasting Midas touch has benefited companies such as Target, Who What Wear and VERSED skincare, among others. She is a seasoned executive with impeccable entrepreneurial acumen. Sally spent over two decades of her career at Target Corporation, first in Apparel Merchandising and then in Marketing, helping to build the bullseye from a regional discount retailer to one of the world’s most recognized and influential global brands.

Sally Mueller

CO-Founder &CEO
Womaness

Sally Mueller

CO-Founder &CEO
Womaness

As the co-founder and CEO of Womaness, Sally is a consummate business builder specializing in retail and brand innovation. Her trend-forecasting Midas touch has benefited companies such as Target, Who What Wear and VERSED skincare, among others. She is a seasoned executive with impeccable entrepreneurial acumen. Sally spent over two decades of her career at Target Corporation, first in Apparel Merchandising and then in Marketing, helping to build the bullseye from a regional discount retailer to one of the world’s most recognized and influential global brands. She developed and implemented Target’s designer program and Design for All platform, transforming the regional discount retailer into a global phenomenon.

 

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew is a 2 time entrepreneur who is now working on her second company, Hyivy Health, created after her recent fight with cervical cancer. Hyivy Health is creating a pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Rachel is a graduate of the University of Waterloo and has been working in various roles in the entrepreneurship ecosystem for over 10 years.

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew is a 2 time entrepreneur who is now working on her second company, Hyivy Health, created after her recent fight with cervical cancer. Hyivy Health is creating a pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Rachel is a graduate of the University of Waterloo and has been working in various roles in the entrepreneurship ecosystem for over 10 years.

 

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude
 

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz is the founder of Tabu - a new kind of sexual wellness brand for bodies that change. Previously, Natalie was the VP of Marketing and Communications at The Chernin Group (TCG). Prior to that, she was an early employee at Collective Health, and recently served as a product advisor to Dadi. She started her career in the crisis communications practice group at Hill & Knowlton Strategies.

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz is the founder of Tabu - a new kind of sexual wellness brand for bodies that change. Previously, Natalie was the VP of Marketing and Communications at The Chernin Group (TCG). Prior to that, she was an early employee at Collective Health, and recently served as a product advisor to Dadi. She started her career in the crisis communications practice group at Hill & Knowlton Strategies.

 

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health
 

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr.

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and of other aging-related conditions. She directs the Mayo Clinic Specialized Center of Research Excellence (SCORE) on Sex Differences. Dr. Mielke is co-Chair of the Sex and Gender Diversity Group for the Alzheimer’s Association Professional Interest Area. She received the John R. Raymond Mentor Award from the Women Scholars Initiative. She is the PI of several NIH-funded clinical- and epidemiological-based grants and has published over 360 manuscripts.

 

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

 

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health
 

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals
 

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University